Evidence map›Paper›PMID 36504569›Full record

ArticleAvicenna journal of medical biotechnology

Evaluation of PLGA-Encapsulated Recombinant GroEL of

Milad Parvane, Shahram Nazarian, Emad Kordbache, Javad Fathi, Mohamad Ebrahim Minae, Mohammad Reza Ramezani

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in Avicenna journal of medical biotechnology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Milad ParvaneBiology Research Center, Faculty of Basic Sciences, Imam Hossein University, Tehran, Iran.
Shahram NazarianBiology Research Center, Faculty of Basic Sciences, Imam Hossein University, Tehran, Iran.
Emad KordbacheBiology Research Center, Faculty of Basic Sciences, Imam Hossein University, Tehran, Iran.
Javad FathiDepartment of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohamad Ebrahim MinaeBiology Research Center, Faculty of Basic Sciences, Imam Hossein University, Tehran, Iran.
Mohammad Reza RamezaniBiology Research Center, Faculty of Basic Sciences, Imam Hossein University, Tehran, Iran.
Imam Hossein University · IRShiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Heat Shock Proteins (HSPs) elicit humoral and cellular immune responses. Due to their high sequence homology, they can be developed as a new immunogen for cross prophylactic and vaccination effects against infectious agents such as Enteropathogenic and Enterohemorrhagic Methods: Recombinant GroEL was expressed in Results: Over-expression in Conclusion: The findings indicated that immunization of the mice with recombinant GroEL of

Indexed as

Heat-Shock ProteinsImmunogenicityNanoparticlesSalmonella typhiVaccines

Identifiers

PMID36504569
PMCPMC9706248
OpenAlexW4294716593

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.